Back to News
Market Impact: 0.15

Detailed Fundamental Analysis

IWMNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
Detailed Fundamental Analysis

A fundamental report on the iShares Russell 2000 ETF (IWM), a Small-Cap Value ETF, details its factor exposures, which are critical for institutional investors assessing its investment profile. The ETF's portfolio is concentrated in the Services sector and Biotechnology & Drugs industry. Factor analysis indicates moderate exposure to Value (56) and Momentum (40), but notably low scores for Quality (11) and Low Volatility (13) on a 1-99 scale, highlighting its specific risk-reward characteristics as a small-cap value fund.

Analysis

The iShares Russell 2000 ETF (IWM) is identified as a Small-Cap Value ETF, with its portfolio exhibiting a notable concentration in the Services sector and the Biotechnology & Drugs industry. This structural weighting suggests a specific investment profile within the broader small-cap market, potentially emphasizing sectors known for higher growth potential but also increased volatility. Validea's fundamental report details IWM's factor exposures, assigning a moderate score of 56 for Value and 40 for Momentum on a 1-99 scale. Critically, the ETF registers significantly low scores for Quality (11) and Low Volatility (13), indicating that its underlying holdings may possess weaker financial health and higher price fluctuations. These low Quality and Low Volatility scores are crucial for institutional investors, as they imply a higher inherent risk profile for IWM despite its value mandate. The factor characteristics align with the typical risk-reward dynamics often associated with small-cap value strategies, particularly those with substantial exposure to the often-volatile biotechnology sector.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWM0.00
NDAQ0.00

Key Decisions for Investors

  • Investors should carefully assess IWM's higher risk profile, driven by its notably low Quality and Low Volatility factor scores, which are characteristic of its small-cap value and biotech-heavy mandate.
  • Consider the implications of the ETF's significant sector concentration in Services and Biotechnology & Drugs, as this introduces specific industry-related risks and opportunities.
  • Evaluate IWM's factor exposures and sector weightings against existing portfolio diversification strategies and overall risk tolerance to ensure alignment with investment objectives.